SCHEMBL17565747

SCHEMBL17565747

COC(=O)c1ccc(Cl)c(OCc2ccc(F)cc2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 2/20 0.57
MAPT P10636 2/20 0.52
RAB9A P51151 2/20 0.52
LMNA P02545 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
KDM5A P29375 2/20 0.51
KDM5B Q9UGL1 2/20 0.51
HDAC6 Q9UBN7 2/20 0.50
HPGD P15428 2/20 0.50
RXRA P19793 1/20 0.50
RXRB P28702 1/20 0.50
MRGPRX4 Q96LA9 4/20 0.49
KMT2A Q03164 3/20 0.49
FFAR4 Q5NUL3 1/20 0.49
HDAC1 Q13547 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15777750 0.86 RAB9A (0.54) HDAC8MAPTRAB9ALMNAL3MBTL1
SCHEMBL559537 0.86 NOTUM (0.58) HDAC8MAPTRAB9ALMNAL3MBTL1
SCHEMBL25210452 0.81 FFAR4 (0.59) MAPTRAB9ALMNAL3MBTL1CYP1A2
SCHEMBL15776567 0.80 CNR2 (0.55) MAPTKDM5AKDM5BMRGPRX4KMT2A
SCHEMBL6066763 0.79 HDAC8 (0.54) HDAC8MAPTRAB9ALMNAHDAC6
SCHEMBL16930354 0.79 ALDH1A1 (0.53) HDAC8MAPTLMNAL3MBTL1CYP1A2
SCHEMBL16055873 0.78 CYP11B1 (0.55) HDAC8MAPTRAB9ALMNAL3MBTL1
SCHEMBL6418760 0.77 MAOB (0.72) MAPTRAB9ALMNAL3MBTL1SMN1; SMN2
SCHEMBL23484500 0.77 HDAC8 (0.47) HDAC8MAPTRAB9ALMNAL3MBTL1
SCHEMBL6066649 0.77 F10 (0.55) MAPTRAB9ACYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9458129-B2 Histone demethylase inhibitors CELGENE QUANTICEL RESEARCH, INC. (US) 2016-10-04 US disclosed
US-9458129-B2 Histone demethylase inhibitors CELGENE QUANTICEL RESEARCH, INC. (US) 2016-10-04 US disclosed
US-20160068507-A1 HISTONE DEMETHYLASE INHIBITORS CELGENE QUANTICEL RESEARCH, INC. 2016-03-10 US disclosed
US-20160068507-A1 HISTONE DEMETHYLASE INHIBITORS CELGENE QUANTICEL RESEARCH, INC. 2016-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160068507-A1 HISTONE DEMETHYLASE INHIBITORS KDM1B, KDM5A, KDM1A HDAC8 44/4885MAPT 2204/4885RAB9A 3347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.